|
Session Descriptions BUSINESS, POLICY AND TECHNOLOGY SESSIONS With technologies and regulations developing at an unprecedented pace, staying on the cutting-edge is crucial to your bottom line. The 2011 DMC and Technology Expo is your ticket to nearly 20 top-notch educational sessions — presented by industry thought leaders, government experts and academia — on the pressing topics affecting your business. Stay tuned for the latest updates on this year’s business program! What Sessions Are Right For You? Business discipline icons are listed by each educational session to help you determine which business, policy and technology sessions are right for you. Click on the icons below to see what sessions apply to that particular business discipline.
A session marked with an asterisk (*) is closed to the media.
Opening General Session | 8:30 AM–9:45 AM
Welcome
HDMA President and CEO John M. Gray will open the 2011 DMC and Technology Expo with an update on HDMA’s ongoing strategic initiatives across the industry, in statehouses and on Capitol Hill. The distribution industry is evolving in response to the challenges and opportunities of the changing healthcare landscape. Hear how HDMA is addressing the latest legislative, regulatory and operational developments affecting the industry — from federal and state pedigree legislation to Risk Evaluation and Mitigation Strategies (REMS), in-transit security and the growth of specialty pharmaceuticals. Learn how the Association is working with the supply chain to promote innovation and industry best practices, while enhancing patient safety, supply chain security and business efficiencies. Keynote Presentation
The full impact of the historic healthcare reform legislation will not be felt until 2014 and beyond, but in the meantime, all industry stakeholders must deal with “Life in the Gap” before new provisions are implemented. At the same time, the industry must prepare for the emerging reality of healthcare reform and try to determine what life will be like in a reformed system in 2014 and beyond. Organizations and individuals also need to be flexible to adjust to additional modifications in the reform agenda, including the push for more widespread reimbursement reform, the growth of transparency and accountability and the relentless quest for value in healthcare.
Discover how score carding can produce business improvements or efficiencies in key areas such as OTC/HBW, EDI, returns, chargebacks, inventory management and more. This session will explore supply chain analytics, including how metrics can facilitate improvements and help you achieve best-in-class outcomes with your trading partners. Speakers: Chris Doerr, Associate Director, Client Financial Services, Cephalon, Inc.
Stay informed of the ever-changing world of controlled substance and listed chemical regulations by exploring recent and upcoming initiatives from a DEA perspective. Trends, upcoming regulations, reporting, quotas, diversion, security and other topics will be covered. An opportunity for questions and answers will be provided. Speaker: Cathy A. Gallagher, Associate Chief Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Agency
 The Role of the Specialty Distributor Gain insight into the capabilities, services and value of distributors in the specialty pharmaceutical sector. This session will present key takeaways from the economic analysis recently conducted by Arthur D. Little Inc. for the Center for Healthcare Supply Chain Research. Speaker: John W. Brennan, President and Managing Director, Arthur D. Little, Inc.
Concurrent Business, Policy and Technology Sessions
More and more, manufacturers are outsourcing distribution and logistics functions to third-party logistics companies (3PLs). Learn about leading practices for engaging with 3PL companies — both as a manufacturer and a distributor — to enhance trade relationships. Speakers: Amy A. Winnen, Director, Trade and Distribution, Vertex Pharmaceuticals, Inc.
The Affordable Care Act includes new provisions that expand and reform the 340B Drug Pricing Program. This session will provide an overview of these changes and their impact on the supply chain. Review the new government requirements for eligibility compliance, program integrity, diversion and the implications of program implementation for supply chain partners. Moderator: Larri A. Short, Esq., Partner, Health Law Group, Arent Fox, LLC
Drug shortages are a challenge for the healthcare community, mainly because they typically appear with little or no warning and significant resources may be needed to manage patients when a particular therapy is in short supply. Learn more about the American Society of Health-System Pharmacists’ efforts to define the scope and causes of drug shortages and how the supply chain can work together to enhance patient safety and minimize disruptions in patient care that are caused by drug shortages. This session will also include a panel discussion addressing key challenges in communications on product availability and explore how to work through these barriers. Speaker: Cynthia Reilly, BS Pharm, Director, Practice Development Division, American Society of Health-System Pharmacists
Concurrent Business, Policy and Technology Sessions
How are supply chain partners successfully collaborating on track-and-trace technology pilot programs? Review 2011 plans for track and trace and serialization and the action steps trading partners are taking as they work toward implementation. Trading partners will discuss their recent activities and future plans to implement serialization and track-and-trace technologies. These real-world examples highlight innovative approaches and lessons learned from this process. Speaker: Michael Celentano, Director, Supply Chain Systems, Purdue Pharma L.P.
Supply Chain Coordination Communication and coordination among supply chain partners is crucial in order to deliver critical medicines and supplies, especially during a severe emergency or pandemic. Learn about Rx Response and other information-sharing sources for the private sector and enjoy real world discussion from manufacturers, distributors, retailers and other emergency preparedness responders. Review lessons learned from pandemic after-action meetings and discuss what barriers can be overcome if supply chain partners work together to address any severe emergency. Moderator: Erin Mullen, RPh, PhD, Assistant Vice President, Rx Response
The Food and Drug Administration Amendments Act of 2007 (FDAAA) provided FDA with powerful authority to impose REMS on drugs and biologics. As a result, REMS requirements are changing the world of drug development, the supply chain and healthcare provision. This session will provide an update on FDA’s REMS policy; how manufacturers, wholesale distributors and others are addressing special issues associated with the opioid REMS; customer verification; registries; assessments; and additional topics. The benefits and challenges of REMS also will be discussed. Speakers: Peyton Howell, MHA, President, Consulting Services, AmerisourceBergen Corporation
Concurrent Business, Policy and Technology Sessions
With the deadline for track-and-trace implementation approaching, this session will compare two transactions — the drug pedigree messaging standard and Advanced Ship Notices — for tracking and tracing items in the pharmaceutical supply chain. Speakers: Steve Tadevich, Director, Account Management, McKesson Corporation
With an ever-increasing number of products that require cold chain handling, it is essential to stay up to date with the latest in cold chain technology and operations. Find out about the most recent advances, challenges and recommended guidelines in the storage and transportation of cold chain and frozen healthcare products. Speaker: TJ Rizzo, Director of Sales, Cold Chain Technologies
Get a leg up on the latest and greatest warehousing technologies in this informative session. Explore how to leverage warehouse technology to reduce inefficiencies in day-to-day operations by improving and creating processes around effective automation strategies. Learn about the practical implementation of technology in today’s warehouse environment and how to measure success. Speaker: Susan Rider, President, Rider & Associates
Morning General Session and Distribution Management Award Presentation | 8:30 AM–9:45 AM
Distribution Management Award Presentation For more information about the nomination process, contact Lisa Gallagher, Director of Member Services, at (703) 885-0251 or e-mail lgallagher@hdmanet.org. Strive for the Best — Never Be Satisfied Simply by a Job Well-Done
Jim Palmer showed he knew how to win the big games as the winning pitcher in the Baltimore Orioles’ first four pennant-clinching games. Elected to the Hall of Fame in 1990, Palmer spent his entire 20-year pitching career with the Orioles, and is the team’s all time leader in virtually every pitching category. He is the only American League Hall of Fame pitcher to win the Cy Young Award three times, and also earned four Gold Glove Awards. Palmer had an 8-3 record with a 2.61 ERA in post-season play, and in 1983 became the only pitcher in baseball history to win a World Series game in three different decades.
The existing patchwork of state pedigree laws continues to challenge manufacturers and distributors alike as they strive to preserve efficiencies in the supply chain. States also are addressing controlled substance issues in a variety of ways, from distributor sales reporting to the regulation of pain management clinics. Get up-to-the-minute updates on state legislative and regulatory activity, including the new emphasis on controlled substance requirements. Speakers: Daniel G. Bellingham, Director, State Government Affairs, HDMA
Learn about the newest strategies and tactics used to increase the security of the supply chain. This session explores industry best practices, latest technologies, and recommendations to combat theft both in warehouses and while in-transit. Speakers: Terry L. Carrico, Vice President, Corporate Security, McKesson Corporation
Delve into the latest updates on federal reimbursement metrics for pharmaceuticals under the Medicare and Medicaid programs. Gain an understanding of the changes and challenges facing the supply chain as the government implements the initiatives brought forth under the Affordable Care Act. Hear the latest on Average Manufacturer Price, Average Wholesale Price, Average Sales Price and other pricing activities of importance for the industry. See what new requirements the federal government may have for distributors and manufacturers, and how these legislative and regulatory changes will affect your bottom line. Speaker: Larri A. Short, Esq., Partner, Health Law Group, Arent Fox, LLC
Discuss ways to reduce the volume of unsalables, increase efficiencies in processing and reduce the amount of non-creditable waste using a Lean Six Sigma approach. Delve into key areas — including inventory management, operations and return policy elements — in an effort to understand the true costs of expired pharmaceutical returns. Speakers: Scott Bradford, Vice President, Reverse Logistics, McKesson Corporation
Sponsored by Purdue Pharma L.P. Explore DEA’s stepped-up scrutiny of controlled substances distribution, with special attention paid to the impact on DEA registrants and actions HDMA members may take to ensure compliance. This session will provide an overview of recent findings and trends, as well as a chance to discuss DEA’s changing regulatory and enforcement standards. The Agency’s regulations surrounding suspicious orders will be highlighted. Speaker: David L. Durkin, Esq., Principal, Olsson Frank Weeda Terman Bode Matz PC
The Facts, Figures and Trends in Healthcare Get a broader picture of the healthcare supply chain facts, figures and trends in an informative session presented by the Center for Healthcare Supply Chain Research, HDMA’s research foundation. Analyze groundbreaking industry benchmarks reported in the second edition of Specialty Pharmaceuticals: Facts Figures and Trends in Healthcare and the 2010-2011 HDMA Factbook. Speakers: Rolando DeCardenas, Vice President, General Manager, Oncology RX Biopharmaceutical Solutions Group, US Oncology What’s In, What’s Out, What’s Ahead:
Take a first look at the latest industry data and emerging market trends for branded and generic pharmaceutical and health and beauty care product sales. Long is an industry thought leader who specializes in analyzing information from IMS Health’s premier sales, prescription, promotional and medical databases. Long offers perspectives on a range of vital pharmaceutical topics, including global market trends, industry forecasts, research and development, marketing practices, blockbuster drugs, patent expirations and generic trends, biotechnology and more. Take advantage of this opportunity to analyze how emerging trends will affect strategic business plans in the coming year and beyond.
Closing General Session | 8:45 AM–11:00 AM
Global Forces Driving Change in Healthcare Distribution
Rapidly surging emerging markets, disruptive new competitors and the latest innovative technologies promise to upend business as we know it. McKinsey & Company has conducted extensive research into the changes facing the global economy in the coming decade and identified five transformational shifts — five Crucibles of Innovation — that will make the world of tomorrow a very different place to do business than the world of today. In this multimedia presentation, explore the five crucibles and their relevance to the global healthcare supply chain. The Road to 2012
With a Republican House and a Democratic Senate, what is Obama’s legislative strategy heading into 2012? How do senior strategists in both parties see the political landscape for the next two years? Who are the favored Republicans to challenge Obama for the White House in 2012? And how will all these storylines converge and interact tomorrow and in the future? Mark Halperin uses his more than 20 years of experience covering national politics and government to explain it all with insight, wit, insider knowledge and no punches pulled. With an eye on what the latest political maneuvering means for big business, international relations, the American economy and the average citizen, Halperin weaves behind-the-scenes anecdotes about the top players in American politics with his trademark rigorous analysis of policy, politics and the media. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HDMA’s Distribution Management Award recognizes HDMA member companies’ efforts to improve the efficiency and effectiveness of the healthcare supply chain and enhance trading partner relationships. All HDMA members are eligible to nominate their company or a valued trading partner for this prestigious award. Nomination forms can be 
 |
|||||||
 |
|||||||
 |
|||||||
|
|||||||
| Privacy and Terms of Use Policies |